P1603: EFFICACY AND SAFETY OF BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN ITP

• Qiu-Sha Huang,
• Hai-Xia Fu,
• Chen-Cong Wang,
• Xiao-Lu Zhu,
• Yun He,
• Qi Chen,
• Jin Wu,
• Kai-Yan Liu,
• Xiao-Jun Huang,
• Xiao-Hui Zhang

Affiliations

Qiu-Sha Huang

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Hai-Xia Fu

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Chen-Cong Wang

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Xiao-Lu Zhu

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Yun He

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Qi Chen

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Jin Wu

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Kai-Yan Liu

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Xiao-Jun Huang

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Xiao-Hui Zhang

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China